Jefferies Sees Limited Impact To Gilead From Regulus' HCV Candidate's Clinical Hold
June 28, 2016 at 16:27 PM EDT
Shares of Regulus Therapeutics Inc (NASDAQ: RGLS) were down almost 48 percent on Tuesday, after the company said Monday the FDA had ...
